➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Last Updated: May 31, 2020

DrugPatentWatch Database Preview

Litigation Details for Teva Pharmaceuticals v. Pfizer, Inc. (D. Mass. 2003)

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Teva Pharmaceuticals v. Pfizer, Inc. (D. Mass. 2003)

Docket   Start Trial Date Filed 2003-01-24
Court District Court, D. Massachusetts Date Terminated 2003-12-09
Cause 28:2201 Declaratory Judgment Assigned To Richard Gaylore Stearns
Jury Demand None Referred To
Patents 4,536,518; 5,248,699
Attorneys Adam R. Gahtan; Anthony L. DeProspo , Jr.; Brendan G. Woodard; C. Kyle Musgrove; Collin O'Connor Udell; Dimitrios T. Drivas; Henry C. Dinger; Jeffrey J. Oelke; John W Bateman; Matthew A. Porter; Robert J. Muldoon , Jr.; Steven J. Lee; Thomas J. Meloro; Timothy C. Blank
Firms Dechert LLP; Henry C. Dinger; Jackson Lewis LLP; Kenyon & Kenyon LLP; Sherin & Lodgen LLP; White & Case; White and Case
Link to Docket External link to docket
Small Molecule Drugs cited in Teva Pharmaceuticals v. Pfizer, Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Teva Pharmaceuticals v. Pfizer, Inc. (D. Mass. 2003)

Date Filed Document No. Description Snippet Link To Document
2003-01-24 1 #39;Its synthesis is described in U.S. Pat. No. 4,536,518, . assigned to Pfizer Inc. Ser'traline hydrochloride…five years crystalline stability. U.S. Fat. No. 4,536,518 does not refer to specific polymorphic crystalline… described and exempli- fied in U.S. Pat. No. 4,536,518 produces the sertraline hydrochloride polymorph…the owner of U.S. Patent No. 5,248,699 (the “‘699 patent”). A copy of the ‘699 patent is attached hereto…United States Patent [191 [11] Patent Number: 5,248,699 Sysko et al. [45] Date of Patent: Sep. 28, 1993 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.